Clinical Trial Update: Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of Tenalisib (RP6530) in locally advanced or metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tenalisib (tenalisib)

Snippet

Sponsor: Rhizen Pharmaceuticals SA | Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-13